Home   |   News    |   Discussions   |   Books   |   Curiosities
Search
Custom Search
Popular Reads

Earthquakes and animal behavior
LHC may produce time travelling particles
Country boys boast bigger junk
Running the numbers on alien life
Uh-oh, placebo
Forgetful? Blame your house
Pill to blame for rise in prostate cancer?
Cat parasite has global ambitions
Carbon monoxide keeps city dwellers happy
Magnetic field alters moral judgments
Stars manufacturing organic matter?
Unnatural selection: Courtesy of The Pill
Men 2% funnier than women
Parasite rewires sexual attraction
Novel psychiatric drugs take aim at gut bacteria
Discussions
General Science

Not-Quite Science

Physics

Climate Change

Science Fiction

Past Forums

Sponsored Links
Browse

Animal Kingdom

Biology

Climate Change

Environment

Evolution

Genetics

Humans

Mind & Brain

Prehistory

Health & Diet

Health Threats

Health & Environment

Health: From The Lab

Mental Health

Reproductive Health

Energy Alternatives

Chemistry

Computing & Electronics

Nanotechnology

Pimping Nature

Robotics & AI

Physics

Space


Curiosities
Sci Shop
Peculiar and bizarre scientific stuff that you didn't even know existed and you don't need.
Books
Book Reviews
Rusty Rockets lists his all-time favorite science titles.
Archives
2012 2011 2010
2009 2008 2007
2006 2005 2004
2003 2002 2001
2000 1999 1998
Feature Archive


4 April 2007
Modified Rabies Virus Could Tackle HIV
by Kate Melville

Scientists from Jefferson Medical College say they have produced viral immunity to an AIDS-like disease by using a weakened rabies virus to deliver HIV-related proteins into non-human primates.

The study, published in the Journal of Infectious Diseases, details how two years after the initial vaccination, four vaccinated rhesus macaques were still protected from disease, even after being "challenged" with a dangerous animal-human virus.

To test the effectiveness of rabies as a delivery vector, the scientists inserted two different viral proteins into the rabies virus genome. One was a glycoprotein on the surface of HIV, while the other was an internal protein from simian immunodeficiency virus (SIV). The modified rabies virus was the same one that has been used for more than 20 years in oral vaccines against rabies in wildlife in Europe.

Four rhesus macaques were immunized with both vaccines, while two animals received only the weakened rabies virus. After they gave the animals an initial vaccination, the researchers then tried two different immune system boosts, but didn't see enhanced immune responses. They then developed a new vector, a viral surface protein from another virus, vesicular stomatitis virus (VSV). Two years after the initial immunization, they gave a booster vaccine with the rabies-VSV vector, and saw SIV/HIV-specific immune responses.

Challenging the animals with SIV, the researchers found that those animals that were given the test vaccine could control the infection. The control animals without the experimental vaccine had high levels of virus and a loss of CD4 cells.

"We still need a vaccine that protects from HIV infection, but protecting against developing disease can be a very important step," researcher Martin Schnell said, adding that he and his colleagues aren't sure how long the viral immunity will last. But he did say this work was a proof of principle, and that future studies in larger groups of animals should be carried out.

Related articles:
HIV's Virulence An Evolutionary Accident
Pimp My Retrovirus

Source: Thomas Jefferson University


Social

Follow Science a GoGo


Home         All The News      Science Forum         Books, Books, Books         Curiosity Shop         About

The terms and conditions governing your use of this website.
Copyright © 1997 - 2012 Science a Go Go and its licensors. All rights reserved.